Abiopharma

🔍 Williams Brinkley Ruth (Executive)

Company: Natera, Inc. (NTRA)

Report Date: 2026-04-24

Detailed Transactions and Holdings:

• Acquired 86 shares of Common Stock (Direct)
  Date: 2026-04-24 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,475.00 | transaction_form_type: 4 | Footnotes: F1, F2

Footnotes:

• F1: Represents the issuance of Restricted Stock Units ("RSUs") to the Reporting Person in lieu of quarterly retainer fees of $17,500 for service on the Issuer's Board of Directors. The RSUs were fully vested at the time of issuance.
• F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.